10% Free customization
The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023. This growth is driven by advancements in genomic research and an increasing focus on precision medicine within the field of oncology. This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Market Introduction
The Asia-Pacific (APAC) Genomic Cancer Panel and Profiling Market is experiencing significant growth, propelled by the rising incidence of cancer and the increasing adoption of personalized medicine across the region. Advances in genomic technologies and the expanding capabilities of next-generation sequencing (NGS) have enhanced the precision of cancer diagnostics and treatment strategies, catering specifically to individual genetic profiles. Governments and healthcare institutions are increasingly investing in healthcare infrastructure and genomic research, further stimulating market expansion. Moreover, collaborations between biotech firms are boosting access to advanced genomic tests. This market's growth is also supported by growing public awareness about the benefits of early cancer detection and targeted therapies, making the APAC region a vital player in the landscape of cancer genomics.Market Segmentation
Segmentation 1: by Application
- Clinical
- Research
Segmentation 2: by End User
- Hospitals
- Clinical and Diagnostic Laboratories
- Research and Academic Institutes
- Other End Users
Segmentation 3: by Country
- China
- Japan
- India
- Australia
- South Korea
- Rest-of-Asia-Pacific
How can this report add value to an organization?
Product/Innovation Strategy: The Asia-Pacific genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.Some of the prominent names in this market are:
- Burning Rock DX
- Genecast Biotechnology Co., Ltd
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
1 Markets
2 By Region
3 Company Profiles
List of Figures
List of Tables
Companies Mentioned
- Burning Rock DX
- Genecast Biotechnology Co., Ltd
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 45 |
Published | May 2024 |
Forecast Period | 2023 - 2033 |
Estimated Market Value ( USD | $ 1.56 Billion |
Forecasted Market Value ( USD | $ 4.78 Billion |
Compound Annual Growth Rate | 11.8% |
Regions Covered | Asia Pacific |
No. of Companies Mentioned | 2 |